Latest Biotech News

Singapore-based Nanyang Biologics (NYB) has entered a business combination agreement valued at $1.5 billion with Nasdaq-listed special purpose acquisition company RF Acquisition Corp II. NYB...

Global biopharma fundraising has experienced a marked slow-down in 2025, with total capital raised through September reaching $47.1 billion, substantially lower than the $86.7 billion raised...

Researchers have constructed the largest genetic map linking human genetics and metabolism by analyzing data from approximately 450,000 individuals via the UK Biobank. Employing nuclear magnetic...

Amgen announced new data from a 12,000-patient trial showing that its cholesterol-lowering drug Repatha (a PCSK9 inhibitor) effectively reduces the risk of death from cardiovascular disease, heart...

A team at the University of Pennsylvania uncovered how a single dose of psilocybin, the active compound in psychedelic mushrooms, rapidly and durably alleviates both chronic pain and...

Researchers at the University of British Columbia demonstrated the first successful human transplant of a kidney converted from blood type A to universal type O using specialized enzyme...

Researchers at Integra Therapeutics, in collaboration with Pompeu Fabra University and the Center for Genomic Regulation, have developed synthetic proteins designed through generative AI that...

Spanish investment firms Asabys Partners and Aliath Bioventures have merged in a strategic consolidation, elevating Asabys' assets under management from $351 million to over $468 million. This...

Researchers have demonstrated unprecedented capabilities of artificial intelligence in protein and genome editing design, surpassing natural biological processes. Collaborations between Integra...

Scientists at the University of British Columbia have achieved the first successful human trial converting a kidney from blood type A to the universal type O using specialized enzymes. Published...

Recent clinical and preclinical studies highlight key therapeutic advances across oncology and neurology. Amgen’s cholesterol-lowering drug Repatha demonstrated cardiovascular event reduction in a...

Artificial intelligence continues to transform drug discovery and genomics through innovative platforms and partnerships. Nanyang Biologics merged with Nasdaq-listed RF Acquisition Corp II to...

Recent studies delve into cancer biology, revealing mechanisms of tumor progression and immune interactions. Genialis and Cleveland Clinic collaborate on AI-assisted biomarkers for pancreatic...

Breakthrough discoveries are advancing understanding and treatment options for neurodegenerative and autoimmune diseases. Studies reveal an autoimmune component in amyotrophic lateral sclerosis,...

Major biotech companies and investors are repositioning amidst shifting priorities. Takeda announces exit from all cell therapy research, ceasing clinical trials and seeking external partners,...

Cutting-edge diagnostic tools and screening programs continue to evolve, enhancing disease detection and monitoring. Rockefeller Center hosted a large-scale hereditary cancer genetic testing...

Innovative techniques are transforming molecular biology and disease research. The University of California San Diego developed a technology mapping complex RNA-protein interaction networks inside...

Artificial intelligence is increasingly central to ensuring drug safety and optimizing biomanufacturing processes. Microsoft’s studies highlight AI’s dual-use potential in protein engineering,...

Researchers at the University of British Columbia have pioneered a first-in-human trial converting blood type A kidneys to universal type O using specialized enzymes. This landmark achievement,...

Japanese pharmaceutical giant Takeda Pharmaceutical Co. Ltd. announced a complete withdrawal from all cell therapy research and development activities. The company will seek external partners to...